Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.49 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11986720 | 0.89 | GAA (0.51) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL31213417 | 0.88 | GAA (0.51) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL9451221 | 0.87 | KMT2A (0.63) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL18672224 | 0.87 | GAA (0.63) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL29420498 | 0.86 | MEN1 (0.49) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL933860 | 0.86 | MEN1 (0.69) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL935280 | 0.86 | CTSL (0.56) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL3818727 | 0.86 | MAPT (0.56) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL31213415 | 0.84 | SMN1; SMN2 (0.51) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL31213402 | 0.84 | MAPT (0.63) | GAAMEN1KMT2AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7557248-B2 | Method of forming a carbon-heteroatom bond | RHODIA CHIMIE (FR) | 2009-07-07 | — | — | US | claimed |
| US-20070243999-A1 | Method of Forming a Carbon-Heteroatom Bond | RHODIA CHIMIE (FR) | 2007-10-18 | — | — | US | claimed |
| US-4410457-A | EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT | SUMITOMO CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
| CN-118880357-A | Benzoxazine derivative and electrochemical synthesis method thereof | 齐齐哈尔医学院 | 2024-11-01 | — | — | CN | disclosed |
| CN-114195676-B | Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs | 广州药本君安医药科技股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-114195676-A | Biarylhydrazine compound and adduct thereof and application of compound in preparation of antitumor drugs | 广州药本君安医药科技股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-9983218-B2 | Indole and indoline derivatives and methods of use thereof | ABBVIE INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-9960359-B2 | Arylamine-based compound and organic light emitting diode comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-9960359-B2 | Arylamine-based compound and organic light emitting diode comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20180024144-A1 | INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF | ABBVIE INC. (US) | 2018-01-25 | — | — | US | disclosed |
| US-9625475-B2 | Indole and indoline derivatives and methods of use thereof | ABBVIE INC. (US) | 2017-04-18 | — | — | US | disclosed |
| WO-1998058649-A1 | SALT COMPLEX FOR LYMPHATIC DELIVERY | DEKK-TEC, INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| EP-0502992-A4 | CONDUCTIVE ADHESIVE USEFUL FOR BONDING A SEMICONDUCTOR DIE TO A CONDUCTIVE SUPPORT BASE | — | 1993-05-26 | — | — | EP | disclosed |
| EP-0502992-A1 | CONDUCTIVE ADHESIVE USEFUL FOR BONDING A SEMICONDUCTOR DIE TO A CONDUCTIVE SUPPORT BASE | ACHESON INDUSTRIES, INC. (US) | 1992-09-16 | — | — | EP | disclosed |
| US-5043102-A | Blend of epoxy resin, unsaturated monomer, free radical catalyst, and silver particles | ADVANCED PRODUCTS, INC. (US) | 1991-08-27 | — | — | US | disclosed |
| WO-1991008575-A1 | CONDUCTIVE ADHESIVE USEFUL FOR BONDING A SEMICONDUCTOR DIE TO A CONDUCTIVE SUPPORT BASE | ADVANCED PRODUCTS, INC. (US) | 1991-06-13 | — | — | WO | disclosed |
| EP-0039230-B1 | CURABLE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-12-11 | — | — | EP | disclosed |
| US-4410457-A | EPOXY REACTIVE SOLVENT, EPOXY RESIN, LATENT HARDENER, EPOXIDE-DIALKYLAMINE ADDUCT | SUMITOMO CHEMICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4360649-A | EPOXY RESIN, EPOXIDE-DIALKYLAMINE ADDUCT, UREA COMPOUND, CURING AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-11-23 | — | — | US | disclosed |
| EP-0039230-A2 | Curable composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180024144-A1 | INDOLE AND INDOLINE DERIVATIVES AND METHODS OF USE THEREOF | IDO1, IDO2, TPH1 | GAA 3876/4885MEN1 1382/4885KMT2A 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.